Champions Oncology, Inc.

NASDAQ:CSBR

Biotechnology

Healthcare
$4.44 -1.17%

-$0.08 today

Market cap
$61.80M
Beta
0.40
P/E (TTM)
-41.0
EPS (TTM)
-$0.16
52W Low $5.50High $9.63

Volume 0.01M

Average 0.01M

Income Statement

Follow revenue through to earnings.

Revenue

$56.94M

FY 2025 · Annual

+13.5% YoY

Operating Income

$4.85M

FY 2025 · Annual

Net Income

$4.70M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue41.04M49.11M53.87M50.16M56.94M
Cost of Revenue21.45M23.63M29.53M29.4M28.39M
Gross Profit19.59M25.48M24.34M20.75M28.56M
Gross Margin47.7%51.9%45.2%41.4%50.1%
Research & Development7.2M9.37M11.55M9.54M6.83M
Selling, General & Admin12.03M15.5M17.24M18.13M16.88M
Operating Expenses19.23M24.87M28.79M27.68M23.71M
Depreciation & Amortization1.18M1.63M2.25M1.87M1.64M
EBITDA1.55M2.21M(3.02M)(5.44M)6.27M
EBITDA Margin3.8%4.5%-5.6%-10.8%11.0%
Operating Income366K607K(4.45M)(6.92M)4.85M
Operating Margin0.9%1.2%-8.3%-13.8%8.5%
Interest Income00000
Interest Expense00000
Other Income / Expenses71K(24K)(818K)(387K)(220K)
Income Before Tax437K583K(5.27M)(7.31M)4.63M
Pre-Tax Margin1.1%1.2%-9.8%-14.6%8.1%
Income Tax Expense75K35K68K(32K)(75K)
Net Income362K548K(5.34M)(7.28M)4.7M
Net Margin0.9%1.1%-9.9%-14.5%8.3%
EPS (Basic)0.030.04(0.39)(0.54)0.34
EPS (Diluted)0.020.04(0.39)(0.54)0.33
Weighted Avg Shares13.14M13.2M13.54M13.55M13.66M
Weighted Avg Shares (Diluted)14.57M14.16M13.54M13.55M14.27M

CSBR Earnings Waterfall · TTM

NASDAQ:CSBR · Revenue to Net Income

Key Ratios

EPS$-0.16
Gross Margin45.6%
Net Margin-4.5%
P/E Ratio-18.1
P/S Ratio6.6

Analysis

$57.9M of revenue converted into -$2.3M of net income for the selected period. Gross margin is 45.6% and net margin is -4.5%, showing how much revenue survives after costs and taxes. EPS is $-0.16, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
8-KCurrent reportOct 16, 2026

How much revenue does CSBR generate?

Champions Oncology, Inc. (CSBR) reported $56.94M of revenue in fiscal 2025.

Is CSBR profitable?

Champions Oncology, Inc. (CSBR) reported $4.70M of net income, with a net margin of 8.3%.